Dih Holding Us, INC 8-K filings

DIH Holding US, Inc. expands its strategic partnership with Zahrawi Group to include Saudi Arabia, aiming to enhance the distribution of rehabilitation solutions across four countries.

DIH Holding US, Inc. successfully closed a public offering of 5,937,100 units, raising approximately $4.6 million in gross proceeds.

DIH Holding US, Inc. has announced the pricing of a $4.6 million public offering of units, each consisting of one share of Class A common stock and one warrant.

DIH Holding US has partnered with Nobis Rehabilitation Partners to integrate its Andago gait and balance training device into all of Nobis' newly established hospitals.

DIH Holding US, Inc. has announced the appointment of Shepherd Center as a new Center of Excellence, aiming to enhance rehabilitation outcomes through advanced robotic technology.

DIH Holding US has named Sheltering Arms Institute as a Center of Excellence, recognizing their commitment to integrating advanced rehabilitation technology.

DIH Holding US, Inc. has released an updated investor presentation highlighting its position as a leader in robotic rehabilitation and human performance research, projecting significant revenue growth for fiscal year 2025.

DIH Holding US, Inc. reported a 39% revenue increase for the second quarter of 2025 and announced a restatement of its first quarter 2025 financials due to revenue recognition errors.

DIH Holding US, Inc. has appointed Dietmar Dold as its new Chief Operating Officer to lead the company's operational strategy and drive global expansion.

DIH Holding US, Inc. announced the formation of its Scientific Advisory Board (SAB) comprised of leading scientists and clinicians to advise on technical and scientific pursuits.

DIH Holding US, Inc. has dismissed BDO AG as its independent auditor and appointed BDO USA, PC, effective September 10, 2024.

DIH Holding US, Inc. held its annual meeting on September 6, 2024, where shareholders voted on key proposals including the election of directors, approval of a potential stock issuance, and ratification of the company's auditor.

DIH Holding US, Inc. has announced the appointment of Haapsalu Neurological Rehabilitation Center in Estonia as its latest Center of Excellence, marking the first such center in the Baltics region.

DIH Holding US, Inc. reported a 24% increase in revenue for the first quarter of fiscal year 2025, reaching $16.2 million, driven by strong growth in device and service revenue.

DIH Holding US, Inc. reported a 19% increase in revenue for fiscal year 2024, reaching $64.5 million, and positive operating cash flow of $5.2 million.

DIH Holding US, Inc. has appointed the Zihlschlacht Rehabilitation Clinic as its first Center of Excellence in Switzerland, recognizing the clinic's leadership in neurorehabilitation.

DIH Holding US, Inc. has completed a private placement of $3.3 million in senior secured convertible debentures, along with warrants, to support working capital and general corporate purposes.

DIH Holding US, Inc. announced a 42.1% revenue increase to $47.1 million for the nine months ended December 31, 2023, driven by strong device sales and expansion into new markets.

DIH Holding US, Inc. releases updated financial information, including unaudited results through December 31, 2023, following its business combination with Aurora Technology Acquisition Corp.

DIH Holding US, Inc. has changed its fiscal year end from December 31 to March 31 to align with its subsidiary.

DIH Holding US, Inc. has published an updated investor presentation on its website, as disclosed in a Form 8-K filing on March 20, 2024.

DIH Holding US, Inc. has dismissed Marcum LLP as its independent auditor and engaged BDO AG, effective March 12, 2024.

DIH Holding US, Inc. has made an investor presentation available on its website, as announced in a Form 8-K filing on March 13, 2024.

DIH Holding US, Inc. has amended its registration rights agreement, granting certain holders the right to register their shares for resale following a recent merger.

DIH Holding US, Inc. has announced a $1.5 million private placement of common stock with OrbiMed, an existing shareholder.

DIH Holding US, a robotics and virtual reality technology provider, has announced a $1.5 million private placement of common stock with OrbiMed as the sole participant.

Aurora Technology Acquisition Corp. has received approval to list its new entity's stock and warrants on Nasdaq, with the business combination closing on February 7, 2024, and trading commencing on February 8, 2024.

Aurora Technology Acquisition Corp. has updated the composition of its board committees following a Nasdaq suspension due to non-compliance with listing rules.

Aurora Technology Acquisition Corp. will have its securities suspended from Nasdaq on January 19, 2024, due to non-compliance with listing rules, while it appeals the decision and works to complete a business combination.

Aurora Technology Acquisition Corp. will have its securities suspended from the Nasdaq Global Market on January 19, 2024, due to non-compliance with listing rules regarding minimum market value.